Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study

by Forschner A, Weißgraeber S, Hadaschik D, Schulze M, Kopp M, Kelkenberg S, Sinnberg T, Garbe C, Biskup S, Battke F
Published 2020-06-01

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and persona...

by Arnulf Stenzl, Florian Battke, Martin Schulze, Maria Kopp, Maximilian Frick, Saskia Biskup, Carolin Blumendeller, Julius Boehme, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick
Published 2021-01-01